These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


371 related items for PubMed ID: 9610800

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Deficiency of the 50 kDa dystrophin-associated-glycoprotein (adhalin) in an Indian autosomal recessive limb girdle muscular dystrophy patient : immunochemical analysis and clinical aspects.
    Handa V, Mital A, Gupta M, Goyle S.
    Neurol India; 2001 Mar; 49(1):19-24. PubMed ID: 11303236
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sarcoglycans in muscular dystrophy.
    Hack AA, Groh ME, McNally EM.
    Microsc Res Tech; 2001 Mar; 48(3-4):167-80. PubMed ID: 10679964
    [Abstract] [Full Text] [Related]

  • 8. The frequency of patients with 50-kd dystrophin-associated glycoprotein (50DAG or adhalin) deficiency in a muscular dystrophy patient population in Japan: immunocytochemical analysis of 50DAG, 43DAG, dystrophin, and utrophin.
    Hayashi YK, Mizuno Y, Yoshida M, Nonaka I, Ozawa E, Arahata K.
    Neurology; 1995 Mar; 45(3 Pt 1):551-4. PubMed ID: 7898714
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemistry of sarcolemmal membrane-associated proteins in formalin-fixed and paraffin-embedded skeletal muscle tissue: a promising tool for the diagnostic evaluation of common muscular dystrophies.
    Suriyonplengsaeng C, Dejthevaporn C, Khongkhatithum C, Sanpapant S, Tubthong N, Pinpradap K, Srinark N, Waisayarat J.
    Diagn Pathol; 2017 Feb 20; 12(1):19. PubMed ID: 28219397
    [Abstract] [Full Text] [Related]

  • 10. Dystrophin-associated protein abnormalities in dystrophin-deficient muscle fibers from symptomatic and asymptomatic Duchenne/Becker muscular dystrophy carriers.
    Di Blasi C, Morandi L, Barresi R, Blasevich F, Cornelio F, Mora M.
    Acta Neuropathol; 1996 Oct 20; 92(4):369-77. PubMed ID: 8891069
    [Abstract] [Full Text] [Related]

  • 11. Abnormalities in alpha-, beta- and gamma-sarcoglycan in patients with limb-girdle muscular dystrophy.
    Sewry CA, Taylor J, Anderson LV, Ozawa E, Pogue R, Piccolo F, Bushby K, Dubowitz V, Muntoni F.
    Neuromuscul Disord; 1996 Dec 20; 6(6):467-74. PubMed ID: 9027857
    [Abstract] [Full Text] [Related]

  • 12. Selective defect of sarcoglycan complex in severe childhood autosomal recessive muscular dystrophy muscle.
    Mizuno Y, Noguchi S, Yamamoto H, Yoshida M, Suzuki A, Hagiwara Y, Hayashi YK, Arahata K, Nonaka I, Hirai S.
    Biochem Biophys Res Commun; 1994 Sep 15; 203(2):979-83. PubMed ID: 8093083
    [Abstract] [Full Text] [Related]

  • 13. alpha-Sarcoglycan (adhalin) deficiency: complete deficiency patients are 5% of childhood-onset dystrophin-normal muscular dystrophy and most partial deficiency patients do not have gene mutations.
    Duggan DJ, Fanin M, Pegoraro E, Angelini C, Hoffman EP.
    J Neurol Sci; 1996 Sep 01; 140(1-2):30-9. PubMed ID: 8866424
    [Abstract] [Full Text] [Related]

  • 14. Extraocular muscle is spared despite the absence of an intact sarcoglycan complex in gamma- or delta-sarcoglycan-deficient mice.
    Porter JD, Merriam AP, Hack AA, Andrade FH, McNally EM.
    Neuromuscul Disord; 2001 Mar 01; 11(2):197-207. PubMed ID: 11257478
    [Abstract] [Full Text] [Related]

  • 15. Sarcoglycan complex: a muscular supporter of dystroglycan-dystrophin interplay?
    Matsumura K, Saito F, Yamada H, Hase A, Sunada Y, Shimizu T.
    Cell Mol Biol (Noisy-le-grand); 1999 Sep 01; 45(6):751-62. PubMed ID: 10541473
    [Abstract] [Full Text] [Related]

  • 16. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.
    Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, Benson MA, Ponting CP, Estournet B, Romero NB, Mercuri E, Voit T, Sewry CA, Guicheney P, Muntoni F.
    Am J Hum Genet; 2001 Dec 01; 69(6):1198-209. PubMed ID: 11592034
    [Abstract] [Full Text] [Related]

  • 17. gamma-sarcoglycan deficiency muscular dystrophy in two adults.
    Lin KL, Wang HS, Chen ST, Ro LS.
    J Formos Med Assoc; 2000 Oct 01; 99(10):789-91. PubMed ID: 11061077
    [Abstract] [Full Text] [Related]

  • 18. Confocal analysis of the dystrophin protein complex in muscular dystrophy.
    Draviam R, Billington L, Senchak A, Hoffman EP, Watkins SC.
    Muscle Nerve; 2001 Feb 01; 24(2):262-72. PubMed ID: 11180210
    [Abstract] [Full Text] [Related]

  • 19. Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophy.
    McNally EM, Duggan D, Gorospe JR, Bönnemann CG, Fanin M, Pegoraro E, Lidov HG, Noguchi S, Ozawa E, Finkel RS, Cruse RP, Angelini C, Kunkel LM, Hoffman EP.
    Hum Mol Genet; 1996 Nov 01; 5(11):1841-7. PubMed ID: 8923014
    [Abstract] [Full Text] [Related]

  • 20. Merosin positive congenital muscular dystrophy with mental deficiency, epilepsy and MRI changes in the cerebral white matter.
    Echenne B, Rivier F, Jellali AJ, Azais M, Mornet D, Pons F.
    Neuromuscul Disord; 1997 May 01; 7(3):187-90. PubMed ID: 9185183
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.